Mymetics Corp (MYMX) financial statements (2021 and earlier)

Company profile

Business Address EUROPEAN EXECUTIVE OFFICE
EPALINGES, CH-1066
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1011220
Cash and cash equivalents1011220
Receivables01000  
Prepaid expense000000 
Prepaid expense and other current assets0
Other undisclosed current assets     04
Total current assets:1112324
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Intangible assets, net (including goodwill)7777999
Goodwill7777777
Intangible assets, net (excluding goodwill)    222
Total noncurrent assets:7777999
TOTAL ASSETS:8888121113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0000011
Accounts payable0000011
Debt53      
Due to related parties5      
Other undisclosed current liabilities   47444039
Total current liabilities:590047454140
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Total noncurrent liabilities:0      
Other undisclosed liabilities 5551    
Total liabilities:59555147454140
Stockholders' equity
Stockholders' equity attributable to parent(51)(47)(43)(39)(33)(30)(27)
Common stock3333332
Additional paid in capital34343434343434
Accumulated other comprehensive income1111111
Accumulated deficit(89)(85)(81)(76)(70)(67)(64)
Total stockholders' equity:(51)(47)(43)(39)(33)(30)(27)
TOTAL LIABILITIES AND EQUITY:8888121113

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1121324
Revenue, net11105
Other income11   
Cost of revenue(0)(0) (2) (0) 
Gross profit:112(1)324
Operating expenses(2)(2)(3)(2)(4)(3)(2)
Other operating expense, net
(Other Expenses)
(0)      
Other undisclosed operating income0 0 0  
Operating income (loss):(1)(2)(2)(3)(0)(1)2
Interest and debt expense(3)(3)(3)(3)(3)(3)(3)
Loss from continuing operations before equity method investments, income taxes:(4)(4)(4)(6)(3)(3)(0)
Other undisclosed income from continuing operations before income taxes   0  6
Income (loss) from continuing operations before income taxes:(4)(4)(4)(6)(3)(3)6
Income tax expense (benefit)(0)(0)(0)0(0)0(0)
Net income (loss) available to common stockholders, diluted:(4)(4)(4)(6)(3)(3)6

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(4)(4)(4)(6)(3)(3)6
Comprehensive income (loss):(4)(4)(4)(6)(3)(3)6
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0) 0(0)0
Comprehensive income (loss), net of tax, attributable to parent:(4)(4)(4)(6)(3)(3)6

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: